Medifast Inc (NYSE:MED) traded at $27.42 at last check on Tuesday, April 30, made a downward move of -22.79% on its previous day’s price.
Looking at the stock we see that its previous close was $35.51. The company has a trailing 12-month PE ratio of 3.01. In terms of its 52-week price range, MED has a high of $109.52 and a low of $30.95. The company’s stock has lost about -26.90% over that past 30 days.
Medifast Inc has a market cap of $298.86 million. With its Forward Dividend at 3.30 and a yield of 12.04%, the company’s investors could be anxious for the MED stock to gain ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $0.67, with the EPS growth for the year raised at $1.9 for 2024 and $3.13 for next year. These figures represent -79.10% and 64.70% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $175.1 million, with a low of $155.6 million and a high of $194.6 million. The median projection represents growth adding up to -40.90% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $694.35 million, or -35.20% down from figures reported last year.
On the other hand, looking at the outlook for the MED stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note that the PEG ratio for the MED stock currently stands at 0.15, and the most recent price level today is -17.05% off its SMA20 and -24.80% from its 50-day simple moving average. The RSI (14) is pointing at 29.39 while the volatility over the past week is 3.95% and jumps to 4.04% over the past one month. The beta value is 1.15, while the average true range (ATR) is currently pointing at 2.05.
Coming back to Medifast Inc (NYSE:MED), we note that the average 3-month trading volume was 391.96K. Current shares outstanding are 10.90 million.
The insiders hold 2.67% of the company’s shares while institutions hold 95.35%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -59.21% down in year-to-date price movement.
